Table 1. Clinical and pathological characterization of non-IBC versus IBC patients.
| Characteristic | Non-IBC | IBC | p value |
| (N = 49) | (N = 28) | ||
| Age | |||
| Rang | 29–73 | 29–65 | |
| Mean ±SD | 53.3±11.3 | 48.9±9.9 | 0.4a |
| NA | 1 | 0 | |
| Tumor size | |||
| Mean ±SD | 4.5±3.4 | 5.8±2.4 | |
| ≤4 | 30(61%) | 6(21%) | 0.001* b |
| >4 | 17(34%) | 21(75%) | |
| NA | 2(5%) | 1(4%) | |
| Tumor grade | |||
| G1 | 6(12%) | 0(0%) | |
| G2 | 33(67%) | 21(75%) | 0.1b |
| G3 | 10(20%) | 6(21%) | |
| NA | 0(0%) | 1(4%) | |
| Axillary Lymph Node Metastasis † | |||
| <4 | 30(61%) | 7(25%) | 0.02b |
| ≥4 | 19(39%) | 21(75%) | |
| ER | |||
| Negative | 27(65%) | 14(50%) | 0.8b |
| Positive | 22 35%) | 14(50%) | |
| PR | |||
| Negative | 29(59%) | 13(46%) | 0.3b |
| Positive | 20(41%) | 15(44%) | |
| Her-2 | |||
| Negative | 37 (76%) | 20(73%) | 1.0b |
| Positive | 12 (24%) | 8(27%) | |
| Lymphovascular invasion | |||
| Negative | 40(82%) | 5(18%) | |
| Positive | 8(16%) | 23(82%) | 0.004* b |
| NA | 1(2%) | 0(0%) | |
| Tumor emboli | |||
| Negative | 44(90%) | 0(0%) | 0.0001* b |
| Positive | 5(10%) | 28(100%) |
Data are reported as means± SD
a
Student’s t-test.
b
Fisher’s exact test.
NA = not available
*
Significant p value calculated by:
†
P value was calculated between <4 including 0 and ≥4.